Thomas F. Isett
Chief Executive Officer presso Transposagen Biopharmaceuticals, Inc.
Patrimonio netto: 2 436 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Chip Clark | M | 56 | 3 anni | |
| Linda Armstrong | M | 61 | 4 anni | |
| Randy Maddux | M | 62 |
iBio CDMO LLC
 iBio CDMO LLC BiotechnologyHealth Technology Part of iBio, Inc., iBio CDMO LLC is a private company that is advancing its immuno-oncology pipeline of antibody therapeutic candidates against hard-to-drug tumor targets. The company is based in Bryan, TX. The company uses its patented discovery platform, which leverages artificial intelligence to consistently deliver antibody candidates against difficult targets. The company's lead candidate, IBIO-101, stimulates anti-tumor immunity by selectively depleting immunosuppressive TREG cells while sparing tumor cell killing T-Effector cells. iBio is pioneering the next generation of antibody therapeutics, leveraging its artificial intelligence-based and epitope steered antibody discovery platform. The company seeks to partner IBIO-400 to develop a safe and effective subunit vaccine capable of differentiating infected from vaccinated animals. The CEO of the company is Thomas F. Isett. | 3 anni |
| Gary Sender | M | 62 | 4 anni | |
| Evert Schimmelpennink | M | 52 | 3 anni | |
| Martin Brenner | M | 54 | 3 anni | |
| Alexandra Kropotova | M | 51 | 4 anni | |
| Felipe Duran | M | 45 | 3 anni | |
| Nishan de Silva | M | 51 |
Transposagen Biopharmaceuticals, Inc.
 Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | - |
| Christopher Young | M | - |
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | - |
| Lisa Middlebrook | F | - | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert Kay | M | 83 | 14 anni | |
| Seymour Flug | M | 88 | 9 anni | |
| John Delta | M | 62 | 1 anni | |
| Philip K. Russell | M | 91 | 10 anni | |
| Arthur Y. Elliott | M | 88 | 9 anni | |
| Terence E. Ryan | M | 69 | 9 anni | |
| James P. Mullaney | M | 52 | 3 anni | |
| Robert Erwin | M | 71 | 12 anni | |
| Olivier Loeillot | M | 54 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 19 | 95.00% |
| Svizzera | 1 | 5.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Thomas F. Isett
- Contatti personali
